The control of the glyoxylate bypass operon (aceBAK) of Escherichia coli is mediated by two regulatory proteins, IclR and FadR. IclR is a repressor protein which has previously been shown to bind to a site which overlaps the aceBAK promoter. FadR is a repressor/activator protein which participates in control of the genes of fatty acid metabolism. A sequence just upstream of the iclR promoter bears a striking resemblance to FadR binding sites found in the fatty acid metabolic genes. The in vitro binding specificity of FadR, determined by oligonucleotide selection, was in good agreement with the sequences of these sites. The ability of FadR to bind to the site associated with iclR was demonstrated by gel shift and DNase I footprint analyses. Disruption of fadR or inactivation of the FadR binding site of iclR decreased the expression of an iclR::lacZ operon fusion, indicating that FadR activates the expression of iclR. It has been reported that disruption of fadR increases the expression of aceBAK. We observed a similar increase when we inactivated the FadR binding site of an iclR ؉ allele. This result suggests that FadR regulates aceBAK indirectly by altering the expression of IclR.
Growth of Escherichia coli on acetate or fatty acids results in the induction of the glyoxylate bypass. The enzymes which compose this pathway, isocitrate lyase and malate synthase ( Fig. 1) , are essential for growth on these carbon sources because they prevent the quantitative loss of the entering carbon as CO 2 in the Krebs cycle (12, 14) . Once induced, the flow of isocitrate through this pathway is controlled by the phosphorylation of isocitrate dehydrogenase (IDH), the Krebs cycle enzyme which competes with isocitrate lyase. Phosphorylation of IDH decreases its activity and so forces isocitrate through the bypass (1, 7, 18) . This phosphorylation cycle is catalyzed by a bifunctional protein, IDH kinase/phosphatase (15, 16) .
The genes which encode the metabolic and regulatory enzymes of the glyoxylate bypass reside in the same operon, aceBAK (2, 17, 20) . The metabolic enzymes, malate synthase and isocitrate lyase, are encoded by aceB and aceA, while aceK encodes IDH kinase/phosphatase. This operon is expressed from a single promoter during growth on acetate (2) .
The aceBAK operon is regulated, at least in part, by a repressor protein expressed from iclR (13, 20, 24, 33) . Mutations in this gene have been shown to result in increased expression of aceBAK during growth on repressing media (e.g., glucose). The protein which this gene encodes, IclR, binds to a site which overlaps the Ϫ35 region of the aceBAK promoter (2, 24, 27) . In addition to regulating aceBAK, IclR also represses its own expression (8) .
The expression of aceBAK is induced during growth on either acetate or fatty acids. The glyoxylate bypass is required for growth on fatty acids because, like acetate, fatty acids enter intermediary metabolism as acetyl coenzyme A. The response of aceBAK to fatty acids has been suggested to be mediated, in part, by FadR (19, 20) . FadR was initially identified because it represses the genes encoding the enzymes of fatty acid degradation (26) . It was subsequently shown to activate the transcription of fabA, a gene whose product participates in unsaturated fatty acid biosynthesis (9) . Mutations in fadR result in increased expression of aceBAK on repressing media, although the effects of these mutations were smaller than those observed for mutations in iclR (19, 20) . In this report, we demonstrate that FadR activates the expression of iclR.
MATERIALS AND METHODS
Materials. DNA modification enzymes were obtained from New England Biolabs or Bethesda Research Laboratories. Oligonucleotides were synthesized by either National Biosciences or Bethesda Research Laboratories. All reagents were the best grades available.
Strain construction. The strains used in this study are listed in Table 1 . Strains W4680 and RS3032 were obtained from the Escherichia coli Genetic Stock Center at Yale University.
An iclR disruption was generated by the insertion of a kanamycin resistance gene at the MluI site in vitro. This site is located at ϩ84 within a coding region of 822 bp. The allele was transferred to the chromosome by recombination (8) .
An iclR::lacZ operon fusion was created by inserting the EcoRI-MluI fragment from iclR (33) between the EcoRI and BamHI sites of plasmid pCL551 (3). This created a fusion which included 1,232 bp upstream of the transcriptional start of iclR and 84 bp from the coding region while deleting 758 bp from the 3Ј end of this gene. A translational termination site was inserted between iclR and lacZ. The allele of lacZ which was used includes its own translational start site. This operon fusion was then transferred to the lac locus of the chromosome by recombination as previously described (29) .
A similar approach was used to insert the intact iclR ϩ gene into the chromosome. The EcoRI-BamHI fragment from plasmid pKL5 (33) was recloned into pCL551 (3). This insert includes 1,232 bp upstream of the transcriptional start site as well as the intact iclR ϩ gene. The insert was then transferred to the chromosome at lac as described previously (29) .
Mutagenesis of the FadR binding site upstream of iclR::lacZ was carried out by using a Transformer site-directed mutagenesis kit obtained from Clontech Laboratories. Residues at both Ϫ56 (T) and Ϫ55 (C) relative to the transcriptional start site were changed to G's. The sequence of the oligonucleotide used for mutagenesis was 5Ј CAACATTAACTCAGGGGATCAGTTCAG 3Ј. The fidelity of the reaction was confirmed by sequence analysis (31) .
Strain construction was performed by P1-mediated transduction. The genetic background of all the strains used in this study was that found in strain W4680.
Growth conditions and enzyme assays. The minimal medium described by Neidhardt et al. (25) , containing 2% glucose, 2% sodium acetate, or 5 mM sodium oleate in 0.5% Brij 58, was used. Cultures were incubated at 37ЊC in a gyratory shaker, and growth was monitored by light scattering at 600 nm. Assays were performed with cultures in the mid-log phase of growth.
Assays for ␤-galactosidase were performed on permeabilized cells as described by Miller (23) . Enzyme activity was corrected for culture density and calculated in Miller units.
IDH phosphatase was assayed by measuring the release of 32 P from phospho-IDH as described previously (15) .
Cloning of fadR. A clone containing the fadR gene was obtained from the Kohara bank (11). This bank is composed of a series of overlapping clones which represent the entire E. coli chromosome carried by a vector. Clone 11G8(244) carries a fragment which corresponds to 25.5 min on the E. coli map, the region which includes fadR. This gene was subcloned into plasmid pBR322 on a 1.3-kb HindIII-EcoRV fragment. Comparison of a partial sequence of this insert with the sequence which has been reported for fadR (6) confirmed the identity of the clone. FadR was overexpressed essentially as described by DiRusso et al. (5) . The gene was amplified from the original plasmid by PCR. The 3Ј primer used for the PCR introduced an NcoI site at the translational start site but did not change the sequence of the protein. The PCR fragment was inserted into expression vector pET11d, which employs the T7 promoter. The region that had been amplified by PCR was sequenced following the isolation of the clone to ensure the fidelity of the reaction.
Purification of FadR. The plasmid which expresses fadR from the T7 promoter was transformed into strain BL21(DE3). This strain carries the gene encoding T7 RNA polymerase under the control of a lac promoter in its chromosome. The culture was grown at 37ЊC in LB medium containing 100 g of ampicillin per ml to late log phase. T7 RNA polymerase was then induced by addition of 0.4 mM isopropylthiogalactopyranoside. Following incubation for 2 h, cells were harvested by centrifugation and FadR was purified as described by DiRusso et al. (5) .
Assay of FadR binding to DNA. Gel shift analysis was used to demonstrate the binding of FadR to the promoter region of iclR. The reaction mixture included 0.8 ng of probe, 10 mM Tris (pH 7.5), 1 mM EDTA, 50 mM NaCl, 5% glycerol, 1 mM dithiothreitol, and 2 g of poly(dI-dC) in 30 l. The probe, which included sequences from Ϫ128 to Ϫ22 relative to the transcriptional start site, was generated by PCR and end labeled by using [␥- 32 P]ATP and T4 polynucleotide kinase. The mixtures were incubated at 20ЊC for 30 min and then subjected to electrophoresis in a 4.5% polyacrylamide gel at 4ЊC. The gels were dried and subjected to autoradiography.
DNase I footprint analysis. DNase I footprint analysis of the FadR-DNA complex was carried out essentially as described by Shih and Towle (32) . The probe, which included sequences from Ϫ128 to ϩ27 relative to the transcriptional start site, was generated by PCR. The 5Ј primer (Ϫ128 to Ϫ110) was end labeled by using [␥-
32 P]ATP and T4 polynucleotide kinase prior to PCR. Standards were prepared by digestion of the probe by the Maxam and Gilbert method (21) .
Determination of the consensus sequence of the FadR binding site. The method developed by Pollock and Treisman (28) was used to determine the binding site specificity of FadR. This method uses the gel shift technique to select sequences capable of binding to FadR from a pool of random sequences. The probe included a region of 31 random nucleotides flanked by constant regions whose sequences were GCTGCTCGAGTTCTCCTCCCACG (5Ј constant region) and GTTCGCGGATCCCGTC (3Ј constant region). The probe was initially labeled by including [␣- 32 P]dCTP during the synthesis of the second strand with Klenow fragment. It was subsequently labeled by including [␣-
32 P]dCTP during PCR amplification. Oligonucleotides capable of binding to FadR were selected by the gel shift technique followed by elution from the gel and amplification by PCR. Following six rounds of selection, the amplified products were ligated into plasmid pT7/T3␣-18 (22) . Forty-four unique isolates were sequenced, and their sequences were compared by using the Pileup program from the Genetics Computer Group package. (Fig. 2) . This site is located just upstream of the iclR promoter, a position which is often found for transcriptional activators (4). We determined the consensus sequence which is required for binding FadR by oligonucleotide rescue in vitro. This method uses the gel shift electrophoresis technique to isolate binding sequences from a pool of random probes (28) (see Materials and Methods). The sequences of 44 independent isolates were compared to determine the binding specificity of FadR (Table 2) .
The consensus binding site for FadR includes 17 bp. This site is composed of a palindrome of 8-bp sequences flanking a single random nucleotide. This consensus is in good agreement with the naturally occurring binding sites of FadR and with the possible site which we identified upstream of iclR (Fig. 2) .
FadR binding to iclR. The ability of FadR to bind to the upstream region of iclR was tested by gel shift analysis. Purified FadR produced a single shifted band when it was added to a fragment which contained the putative FadR binding site from iclR (Ϫ128 to Ϫ22 relative to the transcriptional start site) (Fig. 3, lanes 2 and 3) . Addition of excess unlabeled probe prevented the formation of the shifted band, suggesting that it was competing for FadR (lanes 4 and 5). In contrast, addition of an overlapping fragment from iclR which did not contain the putative FadR binding site (Ϫ128 to Ϫ66) had no effect on the appearance of the shifted band (lanes 6 and 7) . A fragment from the promoter region of aceBAK also had no effect on the binding of FadR to the iclR upstream sequence (lanes 8 and 9) . These results indicated that FadR binds near the promoter of iclR.
The precise location of the FadR binding site was determined by DNase I footprint analysis (Fig. 4) . A single protected region was detected between Ϫ61 and Ϫ43 relative to the start of transcription. This region corresponds to the proposed FadR binding site presented in Fig. 2 .
FadR activates iclR expression. To determine whether FadR regulates iclR expression, we constructed an iclR::lacZ operon fusion and transferred it to the lac locus on the chromosome. Disruption of fadR resulted in a threefold decrease in iclR::lacZ expression during growth on glucose or acetate (Table 3), indicating that FadR activates expression of iclR.
Although it appeared that FadR activates iclR, it was also possible that the effect of the fadR mutation on iclR::lacZ expression had been a secondary consequence of altered cellular metabolism. To address this issue, we inactivated the FadR binding site of iclR by mutagenesis. The consensus sequence which we had determined in vitro (Table 2) suggested that conversion of CT at Ϫ56 and Ϫ55 to GG should greatly reduce the affinity of this site for FadR. This mutation nearly eliminated FadR binding in vitro (data not shown).
Mutation of the FadR binding site decreased expression of iclR::lacZ by a factor of 5 in an iclR ϩ fadR ϩ background (Table  3 ). This decrease did not result from a change in intrinsic promoter activity, since the mutation had no effect in an fadR iclR mutant background (Table 3 ). These observations confirm our conclusion that FadR activates iclR expression.
The effect of inactivation of the FadR binding site was slightly greater than that observed when fadR was disrupted in an iclR ϩ background (Table 3) . Furthermore, the mutation in fadR actually produced a modest increase in the expression of the iclR::lacZ fusion gene which carried the inactivated FadR binding site (Table 3) . These results were expected since IclR represses its own expression (8) . Because these strains were iclR ϩ , mutations in fadR would be expected to decrease the level of IclR. This decrease should partially relieve the repression of iclR::lacZ. Rigorous proof of this explanation would require direct measurements of the level of IclR. This explanation is, however, supported by the effects which we observed when we repeated these measurements in an iclR mutant back- ground. In this background, mutations in fadR and the FadR binding site of iclR had similar effects (Table 3) . Furthermore, mutation of fadR no longer caused an increase in the expression of the iclR::lacZ fusion which carried the inactivated FadR binding site (Table 3) . These results are consistent with our model in which FadR activates iclR expression.
Activation by FadR is dependent on the carbon source. The extent to which FadR activates iclR can be estimated from the effect of inactivation of the FadR binding site on the expression of iclR::lacZ (Table 3) . Although FadR activates iclR expression about fivefold during growth on glucose, it has only a slight effect during growth on oleate. This finding is consistent with the observation that FadR is inactivated during growth on fatty acids (5, 10) .
In a wild-type strain, the levels of expression of the iclR::lacZ fusion were similar during growth on all three of the carbon sources that we tested (Table 3) . This was a surprising result since FadR activates the expression of this construct during growth on glucose and acetate but not during growth on oleate. In contrast, the expression of iclR::lacZ varied over a range of five-to sixfold in strains carrying mutations in iclR and either fadR or the FadR binding site of iclR::lacZ (Table 3) . Expression was also sensitive to the carbon source in strains which retained the ability to regulate iclR::lacZ with either IclR or FadR, although the range was less pronounced (Table 3) . We have not determined the reason for this wide variation in the expression of iclR::lacZ in the mutant strains. However, it appears that FadR regulation and IclR regulation combine to maintain a constant level of expression of iclR under the conditions which we have examined.
FadR affects expression of aceBAK. Disruption of fadR has been reported to increase the expression of aceBAK (20) . This effect might have resulted from a change in the level of IclR. To test this hypothesis, we constructed full-length clones of iclR with and without a functional FadR binding site. These alleles were then transferred to the lac locus of an iclR::kan strain. The strain carrying native iclR was functionally iclR 
DISCUSSION
FadR was originally identified as a repressor which controls the genes of fatty acid metabolism (26) . This protein was subsequently shown to activate transcription of fabA, a gene whose product participates in unsaturated fatty acid biosynthesis (9) . FadR also activates the expression of iclR, the gene which encodes the repressor protein of the glyoxylate bypass operon. FadR accomplishes this task by binding to a site which is just upstream of the iclR promoter.
FadR can act as both a transcriptional repressor and an activator. The effect that it has on a promoter appears to depend on the location of its binding site. FadR acts as a repressor when it binds to a site which overlaps the promoter. In contrast, FadR activates transcription when it binds just upstream of the promoters of fabA and iclR. This finding is consistent with the organization of most E. coli promoters: operators often overlap the promoter, while activators usually bind just upstream (4). Presumably, proteins which overlap the promoter interfere with RNA polymerase binding or promoter clearance, while proteins binding to sequences upstream of the promoter have the potential to assist RNA polymerase.
Previous reports have demonstrated that mutations in fadR yield increased expression of aceBAK (19, 20) . However, aceBAK does not have a sequence which matches the consensus for FadR binding sites and does not appear to bind FadR in vitro (reference 5 and this study). Our results suggest a mechanism for the effect of fadR mutations on aceBAK expres- 
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sion: loss of FadR should result in decreased expression of IclR. This decrease in IclR would yield the observed increase in aceBAK expression. Consistent with this expectation, mutation of the FadR binding site of iclR produced an increase in aceBAK expression which was very similar to that produced by disruption of fadR. Although FadR and IclR mediate the responses of a variety of genes to the carbon source, they also appear to play the paradoxical roles of ensuring that the transcription of iclR does not change under these same conditions. We have made similar observations in assays using an iclR::lacZ gene fusion, suggesting that the level of the IclR protein may be constant as well (unpublished observation). In the absence of FadR and IclR, the expression of an iclR::lacZ operon fusion varied over a fivefold range on the carbon sources that we tested.
IclR probably acts as a general feedback inhibitor of iclR, maintaining constant expression under a variety of conditions. Unlike its behavior in regulating aceBAK, IclR repression of its own expression is only modestly sensitive to the carbon source (8) . Integration host factor (IHF) may be responsible for this differential control by IclR. IHF, which binds just upstream of the aceBAK promoter, enhances the response of IclR to the carbon source. In contrast, iclR does not have an IHF site and so is much less sensitive to the carbon source (30) .
FadR may act specifically to prevent an increase in IclR during growth on fatty acids. This increase was observed during growth on the fatty acid oleate in strains that lacked FadR or the FadR binding site of iclR::lacZ (Table 3) . FadR prevented this increase by activating iclR transcription on carbon sources such as glucose and acetate but not on oleate. This is an unusual mechanism, since E. coli would generally prevent increased expression of a gene by repression. However, repression by FadR would not solve this problem for iclR since FadR is inactivated during growth on fatty acids (references 5 and 10 and this study). Instead, FadR appears to prevent an increase in the expression of iclR during growth on fatty acids by activating the transcription of this gene on all other carbon sources.
